Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Palmitate-induced Endoplasmic Reticulum stress and subsequent C/EBPα Homologous Protein activation attenuates leptin and Insulin-like growth factor 1 expression in the brain.

Cellular signalling | 2016

The peptide hormones Insulin-like growth factor-1 (IGF1) and leptin mediate a myriad of biological effects - both in the peripheral and central nervous systems. The transcription of these two hormones is regulated by the transcription factor C/EBPα, which in turn is negatively regulated by the transcription factor C/EBP Homologous Protein (CHOP), a specific marker of endoplasmic reticulum (ER) stress. In the peripheral system, disturbances in leptin and IGF-1 levels are implicated in a variety of metabolic diseases including obesity, diabetes, atherosclerosis and cardiovascular diseases. Current research suggests a positive correlation between consumption of diets rich in saturated free fatty acids (sFFA) and metabolic diseases. Induction of ER stress and subsequent dysregulation in the expression levels of leptin and IGF-1 have been shown to mediate sFFA-induced metabolic diseases in the peripheral system. Palmitic acid (palmitate), the most commonly consumed sFFA, has been shown to be up-taken by the brain, where it may promote neurodegeneration. However, the extent to which palmitate induces ER stress in the brain and attenuates leptin and IGF1 expression has not been determined. We fed C57BL/6J mice a palmitate-enriched diet and determined effects on the expression levels of leptin and IGF1 in the hippocampus and cortex. We further determined the extent to which ER stress and subsequent CHOP activation mediate the palmitate effects on the transcription of leptin and IGF1. We demonstrate that palmitate induces ER stress and decreases leptin and IGF1 expression by inducing the expression of CHOP. The molecular chaperone 4-phenylbutyric acid (4-PBA), an inhibitor of ER stress, precludes the palmitate-evoked down-regulation of leptin and IGF1 expression. Furthermore, the activation of CHOP in response to ER stress is pivotal in the attenuation of leptin and IGF1 expression as knocking-down CHOP in mice or in SH-SY5Y and Neuro-2a (N2a) cells rescues the palmitate-induced mitigation in leptin and IGF1 expression. Our study implicates for the first time ER stress-induced CHOP activation in the brain as a mechanistic link in the palmitate-induced negative regulation of leptin and IGF1, two neurotrophic cytokines that play an indispensable role in the mammalian brain.

Pubmed ID: 27555288 RIS Download

Additional research tools detected in this publication

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG045264

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

PERK (C33E10) Rabbit mAb (antibody)

RRID:AB_2095847

This monoclonal targets PERK (C33E10) Rabbit mAb

View all literature mentions

IRE1α (14C10) Rabbit mAb (antibody)

RRID:AB_823545

This recombinant monoclonal targets IRE1-alpha

View all literature mentions

IGF1 antibody (antibody)

RRID:AB_308724

This polyclonal targets IGF1

View all literature mentions

Histone H3 (C-16) (antibody)

RRID:AB_2118303

This polyclonal targets unknown

View all literature mentions

ATF6-human (antibody)

RRID:AB_2615056

This unknown targets ATF6

View all literature mentions

ATF-4 (D4B8) Rabbit mAb (antibody)

RRID:AB_2616025

This monoclonal targets ATF-4

View all literature mentions

Anti-β-Actin Antibody (C4) (antibody)

RRID:AB_626632

This monoclonal targets β-Actin

View all literature mentions

CHOP (D46F1) Rabbit mAb (antibody)

RRID:AB_10694399

This monoclonal targets CHOP (D46F1) Rabbit mAb

View all literature mentions

IGF1 antibody (antibody)

RRID:AB_308724

This polyclonal targets IGF1

View all literature mentions

PERK (C33E10) Rabbit mAb (antibody)

RRID:AB_2095847

This monoclonal targets PERK (C33E10) Rabbit mAb

View all literature mentions

IRE1α (14C10) Rabbit mAb (antibody)

RRID:AB_823545

This recombinant monoclonal targets IRE1-alpha

View all literature mentions

Histone H3 (C-16) (antibody)

RRID:AB_2118303

This polyclonal targets unknown

View all literature mentions

ATF-4 (D4B8) Rabbit mAb (antibody)

RRID:AB_2616025

This monoclonal targets ATF-4

View all literature mentions

CHOP (D46F1) Rabbit mAb (antibody)

RRID:AB_10694399

This monoclonal targets CHOP (D46F1) Rabbit mAb

View all literature mentions

Anti-β-Actin Antibody (C4) (antibody)

RRID:AB_626632

This monoclonal targets β-Actin

View all literature mentions

ATF6-human (antibody)

RRID:AB_2615056

This unknown targets ATF6

View all literature mentions